Targeting Angiogenin in Therapy of Amyotropic Lateral Sclerosis

Expert Opinion on Therapeutic Targets - United Kingdom
doi 10.1517/14728222.12.10.1229
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa Healthcare

Related search

Potential New Complication in Drug Therapy Development for Amyotrophic Lateral Sclerosis

Expert Review of Neurotherapeutics
NeuroscienceNeurologyPharmacology
2016English

Anti-Glutamate Therapy in Amyotrophic Lateral Sclerosis: A Trial Using Lamotrigine

Canadian Journal of Neurological Sciences
MedicineNeurology
1993English

Physical Therapy for Individuals With Amyotrophic Lateral Sclerosis: Current Insights

Degenerative Neurological and Neuromuscular Disease
2018English

Imaging the Pathoanatomy of Amyotrophic Lateral Sclerosis in Vivo: Targeting a Propagation-Based Biological Marker

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2017English

Amyotrophic Lateral Sclerosis

Current Opinion in Neurology
Neurology
2016English

Amyotrophic Lateral Sclerosis

2012English

Amyotrophic Lateral Sclerosis

2020English

Primary Lateral Sclerosis

Muscle and Nerve
Molecular NeuroscienceNeurologyPhysiologyCellular
2007English

Primary Lateral Sclerosis

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy